13F

Stock

Nektar Therapeutics

NKTR · held by 2 managers

Reported value

$453.7K

Holders

2

+0 new · −0 exited

Holders’ est. mark

−$33.3K

Price effect on 1 books still in the name

Largest holder

$370.4K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC163.9K$370.4KHeld
Swiss Life Asset Management Ltd36.7K$83.3K−$33.3KCut−$31.1K

Positions as of Q4 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.